6CM
TIL icon

683 Capital Management’s Instil Bio TIL Stock Holding History

683 Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,557
Closed -$660K – 230
2024
Q4 		$660K Buy
+34,557
New +$1.05M 0.04% 133
2023
Q1 		– Sell
-27,257
Closed -$343K – 327
2022
Q4 		$343K Buy
+27,257
New +$1.35M 0.03% 132

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

683 Capital Management's TIL Position: Q1 2025 in Review

683 Capital Management sold out of Instil Bio (TIL) in Q1 2025, closing a stake of 34,557 shares — an estimated $660K sold.

683 Capital Management first reported a position in TIL in Q4 2022 and held it in 2 quarters. The position peaked at $660K in Q4 2024. 43 funds tracked by Wall St. Rank hold TIL as of Q1 2025.

  • 683 Capital Management reported no remaining Instil Bio position as of Q1 2025 after selling out during the quarter.
  • 683 Capital Management sold 34,557 Instil Bio shares in Q1 2025, an estimated $660K.
  • 683 Capital Management first reported a position in Instil Bio in Q4 2022 and held it in 2 quarters.
  • 683 Capital Management's Instil Bio position peaked at $660K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Instil Bio as of Q1 2025.

Based on 683 Capital Management's 13F filing for Q1 2025, filed 15 May 2025.